Escalon Medical Corp. (ESMC)

Escalon Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1	2	1	2	1	2
Market Cap Growth	-40.65%	131.23%	-44.00%	97.55%	-39.74%	67.87%
Enterprise Value	-0	3	2	3	2	2
Last Close Price	0.17	0.32	0.14	0.25	0.13	0.21

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
PE Ratio	1.35	85.45	-	8.37	-	-
PS Ratio	0.11	0.20	0.09	0.15	0.09	0.15
PB Ratio	0.30	1.25	0.57	0.96	0.64	1.07
P/TBV Ratio	0.35	1.94	0.93	1.52	1.25	2.19
P/FCF Ratio	-	6.37	-	5.82	-	1.88
P/OCF Ratio	-	6.31	-	5.70	-	1.86

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
EV/Sales Ratio	-	0.25	0.14	0.24	0.15	0.23
EV/EBITDA Ratio	-	17.66	-	5.59	-	215.16
EV/EBIT Ratio	-	22.68	-	6.12	-	-
EV/FCF Ratio	-	8.02	-	9.19	-	2.88

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Debt / Equity Ratio	0.24	0.27	0.29	0.46	0.82	1.21
Debt / EBITDA Ratio	-	1.01	1.86	1.03	-	4.96
Debt / FCF Ratio	-	1.39	-	2.79	-	2.14
Net Debt / Equity Ratio	-0.56	-0.01	0.17	0	0.41	0.08
Net Debt / EBITDA Ratio	2.69	-0.13	-5.40	0	-1.45	10.91
Net Debt / FCF Ratio	16.20	-0.06	-0.49	0.00	-0.58	0.15
Asset Turnover	1.80	2.47	2.38	2.32	1.97	1.84
Inventory Turnover	3.94	3.48	4.27	4.20	4.04	3.78
Quick Ratio	1.85	0.76	0.87	0.89	0.71	0.80
Current Ratio	2.59	1.72	1.65	1.63	1.39	1.35
Return on Equity (ROE)	57.49%	5.67%	-6.69%	26.77%	1.23%	-3.50%
Return on Assets (ROA)	-8.78%	1.71%	-1.30%	5.71%	-5.41%	-0.37%
Return on Capital Employed (ROCE)	-17.90%	5.80%	-5.00%	19.50%	-21.70%	-1.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Earnings Yield	74.76%	4.40%	-12.07%	24.64%	1.93%	-3.34%
FCF Yield	-11.77%	15.70%	-61.94%	17.18%	-111.88%	53.26%
Buyback Yield / Dilution	-16.28%	-92.20%	45.33%	-82.92%	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error